{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:50:19Z","timestamp":1780044619140,"version":"3.53.1"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["077078\/Z\/05\/A"],"award-info":[{"award-number":["077078\/Z\/05\/A"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["089276"],"award-info":[{"award-number":["089276"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000841","name":"British Infection Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000841","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We investigated the value of susceptibility testing in predicting response in AIDS-associated cryptococcal meningitis using clinical isolates from a randomized controlled trial of antifungal treatment (amphotericin monotherapy, amphotericin with flucytosine, or amphotericin with fluconazole). We found no correlation between antifungal susceptibility and either early or late survival, or fungal clearance.<\/jats:p>","DOI":"10.1093\/cid\/ciaa1544","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T11:12:47Z","timestamp":1602501167000},"page":"e2338-e2341","source":"Crossref","is-referenced-by-count":17,"title":["Antifungal Susceptibility Does Not Correlate With Fungal Clearance or Survival in AIDS-Associated Cryptococcal Meningitis"],"prefix":"10.1093","volume":"73","author":[{"given":"Lucy","family":"O\u2019Connor","sequence":"first","affiliation":[{"name":"Guy\u2019s and St Thomas\u2019 NHS Trust, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duong","family":"Van Anh","sequence":"additional","affiliation":[{"name":"Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Thi Hong","family":"Chau","sequence":"additional","affiliation":[{"name":"Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Van Vinh","family":"Chau","sequence":"additional","affiliation":[{"name":"Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan Nguyen Phu","family":"Huong","sequence":"additional","affiliation":[{"name":"Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Wolbers","sequence":"additional","affiliation":[{"name":"Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy N","family":"Day","sequence":"additional","affiliation":[{"name":"Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"key":"2021100522430080600_CIT0001","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day","year":"2013","journal-title":"N Engl J Med"},{"key":"2021100522430080600_CIT0002","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal combinations for treatment of cryptococcal meningitis in Africa","volume":"378","author":"Molloy","year":"2018","journal-title":"N Engl J Med"},{"key":"2021100522430080600_CIT0003","doi-asserted-by":"crossref","first-page":"e02261","DOI":"10.1128\/AAC.02261-19","article-title":"Comparison of MIC test strip and sensititre YeastOne with the broth microdilution reference methods CLSI and EUCAST for in vitro antifungal susceptibility testing of Cryptococcus neoformans.","volume":"64","author":"Delma","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2021100522430080600_CIT0004","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.riam.2009.02.001","article-title":"Fluconazole and amphotericin B susceptibility testing of Cryptococcus neoformans: results of minimal inhibitory concentrations against 265 isolates from HIV-positive patients before and after two or more months of antifungal therapy","volume":"26","author":"Arechavala","year":"2009","journal-title":"Rev Iberoam Micol"},{"key":"2021100522430080600_CIT0005","first-page":"795","article-title":"Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with\/without fluconazole prophylaxis","volume":"89","author":"Manosuthi","year":"2006","journal-title":"J Med Assoc Thai"},{"key":"2021100522430080600_CIT0006","doi-asserted-by":"crossref","first-page":"e00091","DOI":"10.1128\/AAC.02108-16","article-title":"Physiological differences in Cryptococcus neoformans strains in vitro versus in vivo and their effects on antifungal susceptibility","volume":"61","author":"Grossman","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021100522430080600_CIT0007","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/clinids\/22.2.322","article-title":"Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing","volume":"22","author":"Witt","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2021100522430080600_CIT0008","doi-asserted-by":"crossref","first-page":"ofw076","DOI":"10.1093\/ofid\/ofw076","article-title":"Retrospective study of Cryptococcal meningitis with elevated minimum inhibitory concentration to fluconazole in immunocompromised patients","volume":"3","author":"Nasri","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2021100522430080600_CIT0009","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1128\/AAC.01520-05","article-title":"Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis","volume":"50","author":"Dannaoui","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2021100522430080600_CIT0010","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1590\/s1678-9946201759049","article-title":"Cryptococcus neoformans and C. Gattii isolates from both HIV-infected and uninfected patients: Antifungal susceptibility and outcome of cryptococcal disease","volume":"59","author":"Nascimento","year":"2017","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"2021100522430080600_CIT0011","doi-asserted-by":"crossref","first-page":"e00091","DOI":"10.1128\/mBio.00091-10","article-title":"Mixed infections and in vivo evolution in the human fungal pathogen Cryptococcus neoformans","volume":"1","author":"Desnos-Ollivier","year":"2010","journal-title":"MBio"},{"key":"2021100522430080600_CIT0012","doi-asserted-by":"crossref","first-page":"e02575","DOI":"10.1128\/mBio.02575-19","article-title":"Fluconazole monotherapy is a suboptimal option for initial treatment of cryptococcal meningitis because of emergence of resistance","volume":"10","author":"Hope","year":"2019","journal-title":"MBio"},{"key":"2021100522430080600_CIT0013","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1128\/AAC.00295-09","article-title":"Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence","volume":"53","author":"Sionov","year":"2009","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa1544\/33879558\/ciaa1544.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/7\/e2338\/40511959\/ciaa1544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/7\/e2338\/40511959\/ciaa1544.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:51:25Z","timestamp":1633740685000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/7\/e2338\/5922781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":13,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,10,14]]},"published-print":{"date-parts":[[2021,10,5]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1544","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2020,10,14]]}}}